Mutations in the RYR2 gene were found in ≈60% of patients with CPVT [18] and concentrated mainly in three specific regions of the ryanodine receptor 2 (RYR2) [18,19]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.